Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

× No keyword cloud information.

184 in total

1. Pharmacokinetic approach to the clinical use of lidocaine intravenously.

Authors: D J Greenblatt; V Bolognini; J Koch-Weser; J S Harmatz
Journal: JAMA Date: 1976-07-19 Impact factor: 56.272

2. Response optimization of drug dosage: antiarrhythmic studies with tocainide.

Authors: P J Meffin; R A Winkle; T F Blaschke; J Fitzgerald; D C Harrison; S R Harapat; P A Bell
Journal: Clin Pharmacol Ther Date: 1977-07 Impact factor: 6.875

3. Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs.

Authors: N O Fowler; D McCall; T C Chou; J C Holmes; I B Hanenson
Journal: Am J Cardiol Date: 1976-02 Impact factor: 2.778

Review 4. Clinical applications of the pharmacokinetics of lidocaine.

Authors: N L Benowitz
Journal: Cardiovasc Clin Date: 1974

5. The convulsant potency of lidocaine and its N-dealkylated metabolites.

Authors: J Blumer; J M Strong; A J Atkinson
Journal: J Pharmacol Exp Ther Date: 1973-07 Impact factor: 4.030

6. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

Authors: M B Rosenbaum; P A Chiale; D Ryba; M V Elizari
Journal: Am J Cardiol Date: 1974-08 Impact factor: 2.778

7. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Authors: I Odar-Cederlöf; O Borgå
Journal: Eur J Clin Pharmacol Date: 1974 Impact factor: 2.953

8. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.

Authors: J Koch-Weser; S W Klein; L L Foo-Canto; J A Kastor; R W DeSanctis
Journal: N Engl J Med Date: 1969-12-04 Impact factor: 91.245

Review 9. Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.

Authors: M R Rosen; A L Wit; B F Hoffman
Journal: Am Heart J Date: 1975-05 Impact factor: 4.749

10. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors: B N Singh; E M Vaughan Williams
Journal: Br J Pharmacol Date: 1970-08 Impact factor: 8.739

9 in total

Review 1. [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].

Authors: W Schmitz
Journal: Klin Wochenschr Date: 1980-09-15

Review 2. Clinical relevance of pharmacokinetics.

Authors: G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal: Clin Pharmacokinet Date: 1980 Mar-Apr Impact factor: 6.447

3. On the interaction between phenytoin and digoxin.

Authors: H Rameis
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

Review 4. Adverse effects of antiarrhythmic drugs.

Authors: J B Schwartz; D Keefe; D C Harrison
Journal: Drugs Date: 1981-01 Impact factor: 9.546

5. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.

Authors: R A Allen-Narker; C J Roberts; A J Marshall; S C Jordan; D W Barritt; R M Goodfellow
Journal: Br J Clin Pharmacol Date: 1984-11 Impact factor: 4.335

6. The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmias.

Authors: P Fechter; H R Ha; F Follath; F Nager
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.